|
Primary prevention
Citations 421-430 of 558 total displayed.
|
Past content
(since Feb 1999):
|
- Articles
Influence of Tamoxifen on Carotid Intima-Media Thickness in Postmenopausal Women
- T. Simon, P. Boutouyrie, J. M. Simon, B. Laloux, C. Tournigand, A. I. Tropeano, S. Laurent, and P. Jaillon
Circulation published November 11, 2002, doi:10.1161/01.CIR.0000041044.93571.CA
[Abstract]
- Clinical Investigations and Reports
Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial
- Alberto Zanchetti, M. Gene Bond, Michael Hennig, Albrecht Neiss, Giuseppe Mancia, Cesare Dal Palù, Lennart Hansson, Bruno Magnani, Karl-Heinz Rahn, John L. Reid, Josè Rodicio, Michel Safar, Lothar Eckes, Paolo Rizzini on behalf of the ELSA investigators
Circulation 2002;106:2422-2427; published online before print as doi:10.1161/01.CIR.0000039288.86470.DD
[Abstract]
[Full text]
- Articles
Impairment in Cardiac Autonomic Regulation Preceding Arterial Hypertension in Humans. Insights From Spectral Analysis of Beat-by-Beat Cardiovascular Variability
- Daniela Lucini, Giuseppe Sandro Mela, Alberto Malliani, and Massimo Pagani
Circulation published October 28, 2002, doi:10.1161/01.CIR.0000039106.89299.AB
[Abstract]
- Articles
Effect of Atorvastatin on High-Density Lipoprotein Apolipoprotein A-I Production and Clearance in the New Zealand White Rabbit
- Shirya Rashid, Kristine D. Uffelman, P. Hugh R. Barrett, and Gary F. Lewis
Circulation published October 28, 2002, doi:10.1161/01.CIR.0000038303.84249.4A
[Abstract]
- Clinical Investigations and Reports
Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial
- Alberto Zanchetti, M. Gene Bond, Michael Hennig, Albrecht Neiss, Giuseppe Mancia, Cesare Dal Palù, Lennart Hansson, Bruno Magnani, Karl-Heinz Rahn, John L. Reid, Josè Rodicio, Michel Safar, Lothar Eckes, Paolo Rizzini on behalf of the ELSA investigators
Circulation published October 21, 2002, doi:10.1161/01.CIR.0000039288.86470.DD
[Abstract]
[Full text]
- Editorials
Low-Density Lipoprotein Lowering and Atherosclerosis Progression: Does More Mean Less?
- Prediman K. Shah
Circulation 2002;106:2039-2040, doi:10.1161/01.CIR.0000037742.25731.3D
[Full text]
- Editorials
Acute Pulmonary Embolism: Don’t Ignore the Platelet
- Piotr Sobieszczyk, Michael C. Fishbein, and Samuel Z. Goldhaber
Circulation 2002;106:1748-1749, doi:10.1161/01.CIR.0000035277.48823.01
[Full text]
- Special Reports
World Heart Day 2002: The International Burden of Cardiovascular Disease: Responding to the Emerging Global Epidemic
- Robert O. Bonow, Lynn A. Smaha, Sidney C. Smith, Jr, George A. Mensah, and Claude Lenfant
Circulation 2002;106:1602-1605, doi:10.1161/01.CIR.0000035036.22612.2B
[Full text]
- Cardiology Patient Pages
Pulmonary Embolism and Deep Vein Thrombosis
- Samuel Z. Goldhaber and Ruth B. Morrison
Circulation 2002;106:1436-1438, doi:10.1161/01.CIR.0000031167.64088.F6
[Full text]
- Clinical Investigations and Reports
Simvastatin Lowers C-Reactive Protein Within 14 Days: An Effect Independent of Low-Density Lipoprotein Cholesterol Reduction
- Julie K. Plenge, Teri L. Hernandez, Kathleen M. Weil, Paul Poirier, Gary K. Grunwald, Santica M. Marcovina, and Robert H. Eckel
Circulation 2002;106:1447-1452; published online before print as doi:10.1161/01.CIR.0000029743.68247.31
[Abstract]
[Full text]
|
|
